Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus

Abstract

Background

The importance of autotaxin, an enzyme that catalyzes lysophospholipid production, has recently been recognized in various diseases, including cancer and autoimmune diseases. Herein, we examined the role of autotaxin in systemic lupus erythematosus (SLE), utilizing data from ImmuNexUT, a comprehensive database consisting of transcriptome data and expression quantitative trait locus (eQTL) data of immune cells from patients with immune-mediated disorders.

Methods

Serum autotaxin concentrations in patients with SLE and healthy controls (HCs) were compared. The transcriptome data of patients with SLE and age- and sex-matched HCs were obtained from ImmuNexUT. The expression of ENPP2, the gene encoding autotaxin, was examined in peripheral blood immune cells. Next, weighted gene correlation network analysis (WGCNA) was performed to identify genes with expression patterns similar to ENPP2. The ImmuNexUT eQTL database and public epigenomic databases were used to infer the relationship between autotaxin and pathogenesis of SLE.

Results

Autotaxin levels were elevated in the serum of patients with SLE compared to HCs. Furthermore, the expression of ENPP2 was higher in plasmacytoid dendritic cells (pDCs) than in other immune cell subsets, and its expression was elevated in pDCs of patients with SLE compared to HCs. In WGCNA, ENPP2 belonged to a module that correlated with disease activity. This module was enriched in interferon-associated genes and included genes whose expression was influenced by single-nucleotide polymorphisms associated with SLE, suggesting that it is a key module connecting genetic risk factors of SLE with disease pathogenesis. Analysis utilizing the ImmuNexUT eQTL database and public epigenomic databases suggested that the increased expression of ENPP2 in pDCs from patients with SLE may be caused by increased expression of interferon-associated genes and increased binding of STAT3 complexes to the regulatory region of ENPP2.

Conclusions

Autotaxin may play a critical role in connecting genetic risk factors of SLE to disease pathogenesis in pDCs.

Keywords

systematic lupus erythematosus dendritic cells autotaxin

Get full access to this article

View all access options for this article.

References

Gräler

Goetzl

. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 2002; 1582: 168–174. DOI: 10.1016/s1388-1981(02)00152-x.

Kurano

Miyagaki

Miyagawa

, et al. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma. J Dermatol 2018; 45: 571–579. DOI: 10.1111/1346-8138.14278.

Iwata

Kitajima

Yamahana

, et al. Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A(1) in patients with lupus nephritis. Int J Rheum Dis 2021; 24: 231–239. DOI: 10.1111/1756-185x.14031.

Sawada

Kurano

Shirai

, et al. Serum phosphatidylserine-specific phospholipase A(1) as a novel biomarker for monitoring systemic lupus erythematosus disease activity. Int J Rheum Dis 2019; 22: 2059–2066. DOI: 10.1111/1756-185x.13689.

Morita

Kurano

Morita

, et al. Urinary autotaxin concentrations are associated with kidney injury. Clin Chim Acta 2020; 509: 156–165. DOI: 10.1016/j.cca.2020.06.019.

Fike

Elcheva

Rahman

ZSM

. The post-GWAS era: how to validate the contribution of gene variants in lupus. Curr Rheumatol Rep 2019; 21: 3–123. DOI: 10.1007/s11926-019-0801-5.

Ota

Nagafuchi

Hatano

, et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 2021; 184: 3006–3021. DOI: 10.1016/j.cell.2021.03.056.

Nakamura

Igarashi

Ide

, et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 2008; 388: 51–58. DOI: 10.1016/j.cca.2007.10.005.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725. DOI: 10.1002/art.1780400928.

10.

Bortoluzzi

Furini

Campanaro

, et al. Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up. Lupus 2017; 26: 616–622. DOI: 10.1177/0961203316671814.

11.

Gladman

Ibañez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.

12.

Robinson

McCarthy

edgeR

. A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England) 2010; 26: 139–140. DOI: 10.1093/bioinformatics/btp616.

13.

Jiao

Sherman

Huang

, et al. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics (Oxford, England) 2012; 28: 1805–1806. DOI: 10.1093/bioinformatics/bts251.

14.

Jassal

Matthews

Viteri

, et al. The reactome pathway knowledgebase. Nucleic Acids Res 2020; 48: D498–d503. DOI: 10.1093/nar/gkz1031.

15.

Stegle

Parts

Piipari

, et al. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat Protoc 2012; 7: 500–507. DOI: 10.1038/nprot.2011.457.

16.

Calderon

Nguyen

MLT

Mezger

, et al. Landscape of stimulation-responsive chromatin across diverse human immune cells. Nat Genet 2019; 51: 1494–1505. DOI: 10.1038/s41588-019-0505-9.

17.

Kheradpour

Kellis

. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res 2014; 42: 2976–2987. DOI: 10.1093/nar/gkt1249.

18.

Fornes

Castro-Mondragon

Khan

, et al. Jaspar 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 2020; 48: D87–d92. DOI: 10.1093/nar/gkz1001.

19.

Zhang

Cheng

Zhang

, et al. ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway. Mol Med Rep 2018; 17: 4245–4252. DOI: 10.3892/mmr.2018.8392.

20.

Masuda

Nakamura

Izutsu

, et al. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 2008; 143: 60–70. DOI: 10.1111/j.1365-2141.2008.07325.x.

21.

Tokuhara

Kurano

Shimamoto

, et al. A new enzyme immunoassay for the quantitative determination of classical autotaxins (ATXα, ATXβ, and ATXγ) and novel autotaxins (ATXδ and ATXε). PLoS One 2015; 10: e0130074. DOI: 10.1371/journal.pone.0130074.

22.

Nikitopoulou

Fanidis

Ntatsoulis

, et al. Increased autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells. Int J Mol Sci; 2021: 22. DOI: 10.3390/ijms221810006.

23.

Molineros

Chua

Sun

, et al. Evaluation of SLE susceptibility genes in Malaysians. Autoimmune Dis 2014; 2014: 305436. DOI: 10.1155/2014/305436.

24.

Bentham

Morris

Graham

DSC

, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 2015; 47: 1457–1464. DOI: 10.1038/ng.3434.

25.

Moore

Purcaro

Pratt

, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 2020; 583: 699–710. DOI: 10.1038/s41586-020-2493-4.

26.

Ward

Kellis

. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012; 40: D930–934. DOI: 10.1093/nar/gkr917.

27.

Magkrioti

Galaris

Kanellopoulou

, et al. Autotaxin and chronic inflammatory diseases. J Autoimmun 2019; 104: 102327. DOI: 10.1016/j.jaut.2019.102327.

28.

Song

Guan

Zhao

, et al. Type I interferons function as autocrine and paracrine factors to induce autotaxin in response to TLR activation. PLoS One 2015; 10: e0136629. DOI: 10.1371/journal.pone.0136629.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB